Included in the formulation
Kaleflon
raw materials.
locally inwards externally
АТХ:V.03.A.X Other medications
Pharmacodynamics:It has anti-inflammatory and stimulating reparative processes for GI diseases.
Pharmacokinetics:Not described.
Indications:Peptic ulcer of the stomach and duodenum, acute and chronic (in the phase of exacerbation) gastritis, including with concomitant inflammatory diseases of the gallbladder and bile ducts.
XI.K20-K31.K26 Duodenal ulcer
XI.K20-K31.K25 Stomach ulcer
XI.K20-K31.K29 Gastritis and duodenitis
XI.K50-K52.K52 Other non-infectious gastroenteritis and colitis
Contraindications:Hypersensitivity.
Pregnancy and lactation:FDA Action Category - not determined.
Adequate and well-controlled studies on humans and animals have not been conducted. There is no information on the penetration into breast milk.
Dosing and Administration:Take inside after eating 0.1-0.2 g 3 times per day. The course of treatment usually lasts 3-4 weeks (up to 6 weeks).The drug can be prescribed together with antacid (reducing the acidity of the stomach) and spasmolytic (spasmodic) remedies.
Side effects:Allergic reactions.
Special instructions:No data.